Skip to main content
. Author manuscript; available in PMC: 2019 Jun 5.
Published in final edited form as: Cell Metab. 2018 May 10;27(6):1212–1221.e3. doi: 10.1016/j.cmet.2018.04.010

Figure 3. Cardiovascular Disease Risk Factors.

Figure 3

eTRF dramatically lowered (A) systolic blood pressure and (B) diastolic blood pressure in the morning. However, it increased or tended to increase morning values for (E) resting heart rate, (I) triglycerides, and, in turn, (F) total cholesterol. The (C) augmentation index, (D) pulse wave velocity, (G) LDL cholesterol, and (H) HDL cholesterol were unaffected.

All data are paired, with N=8 completers in each arm. Data are presented as least squares mean ± SEM. * p ≤ 0.05. See also Table S2.